Especially early in the COVID-19 pandemic, it seemed like not a week went by when another article (or several) appeared, including by me, giving advice to companies on how to better protect their trade secrets especially with exponentially increased remote work, among other things. To be sure, there are increased risks to trade secrets resulting from the pandemic. But as savvy in-house counsel know, all companies need a comprehensive trade secrets management program even aside from the pandemic. So what should companies be worried about when it comes to trade secrets? I recently had the opportunity to speak with in-house counsel from the bio-tech, pharmaceutical and materials industries to discuss the top concerns that keep them up at night when it comes to trade secrets, both before and now in light of COVID-19. Here are some of the takeaways that I learned from these discussions.